Clinical trial
Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in…
NCT00418262 · University of Oklahoma, Other · Completed
Key facts
| NCT number | NCT00418262 |
|---|---|
| Title | Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD |
| Official title | An Open-label Study of the Long Term Tolerability and Safety of Atomoxetine in Treating the Inattention, Impulsivity and Hyperactivity in Children With Fetal-Alcohol Syndrome or Effects. |
| Acronym | B4Z-US-050 |
| Lead sponsor | University of Oklahoma, Other |
| Collaborators | Mark L. Wolraich |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Fetal Alcohol Syndrome, Attention Deficit Hyperactivity Disorder (ADHD) |
| Intervention type | Drug |
| Interventions | Atomoxetine |
| Enrollment | 27 |
| Start date | Aug 1, 2005 |
| Primary completion | Apr 22, 2015 |
| Completion | Apr 22, 2015 |
| First posted | Jan 4, 2007 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: